Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926276 · ClinicalTrials.gov registry record · Phase 4
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT00926276: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT00926276 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00926276, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of fundoplication in premature infants with GERD and BPD.
Interventions
- PROCEDURE Fundoplication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-05 |
| Phase | Phase 4 |
What the finished NCT00926276 record still lists
NCT00926276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Fundoplication is the first listed.
NCT00926276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00926276 about?
NCT00926276 is a clinical study titled "The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia". The purpose of this study is to evaluate the efficacy of fundoplication in premature infants with GERD and BPD.
What is the current status of trial NCT00926276?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2009-06. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00926276?
The interventions under investigation include: Fundoplication (PROCEDURE).
Who is sponsoring clinical trial NCT00926276?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00926276's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia